170885 ⎘
Detection or diagnosis of diseases; Gynecology or obstetrics Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
WEARING ARTICLE PROVIDED WITH TEST STRIP FOR DETECTING AMNIOTIC FLUID MARKER
#213-CIS RETINOIC ACID AND NEURODEVELOPMENT DISORDERS
#3INFLAMMATORY DISEASE GENE PANEL
#4STRUCTURE-BASED PEPTIDES FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES IN PREECLAMPSIA
#5DETECTION OF PREDICTORS OF PREECLAMPSIA
#6BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#7CIRCULATING RNA SIGNATURES SPECIFIC TO PREECLAMPSIA
#8COMBINATIONS OF CELL FREE NUCLEIC ACIDS
#9METHOD OF PROCESSING A BIOLOGICAL SAMPLE
#10KITS AND METHODS TO DISTINGUISH FALSE LABOR AND TRUE LABOR
#11ASSESSMENT OF PREECLAMPSIA USING ASSAYS FOR FREE AND DISSOCIATED PLACENTAL GROWTH FACTOR
#12ANALYSIS METHOD FOR PREECLAMPSIA DIAGNOSIS USING METHYLATION LEVEL IN CPG SITE
#13PREECLAMPSIA DIAGNOSTIC DEVICES, SYSTEMS AND METHODS
#14SYSTEMS AND METHODS TO IDENTIFY AND TREAT SUBJECTS AT RISK FOR OBSTETRICAL COMPLICATIONS
#15BIOMARKER PANELS AND METHODS FOR PREDICTING PREECLAMPSIA
#16TOOLS FOR PREDICTING THE RISK OF PRETERM BIRTH
#17MEANS AND METHODS APPLYING sFlt-1/PIGF OR ENDOGLIN/PIGF RATIO TO RULE OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
#18METHODS FOR PREDICTION AND MONITORING OF SPONTANEOUS PRETERM BIRTH
#19METHODS OF PREPARING AND ANALYZING SAMPLES FOR BIOMARKERS ASSOCIATED WITH PLACENTA ACCRETA
#20SHBG AND IBP4 ANTIBODIES AND METHODS USING SAME
#21BIOMARKERS FOR PREDICTING PRETERM BIRTH DUE TO PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) VERSUS IDIOPATHIC SPONTANEOUS LABOR (PTL)
#22NOVEL IMMUNODIAGNOSTIC DEVICE FOR DETERMINING NORMAL AND ABNORMAL PREGNANCY BY MEASURING DISTRIBUTION RATIO OF BETA CORE FRAGMENT HCG
#23Biomarkers For Detecting Human Glycogen Phosphorylase Isoenzyme BB
#24BIOMARKERS FOR PROGNOSIS OF EARLY ONSET PREECLAMPSIA
#25RATIOS OF sFlt-1 TO P1GF OR ENDOGLIN TO P1GF AS BIOMARKERS FOR PREECLAMPSIA RELATED ADVERSE OUTCOMES AFTER BIRTH
#26METHODS OF PREDICTING PRE TERM BIRTH FROM PREECLAMPSIA USING METABOLIC AND PROTEIN BIOMARKERS
#27CELL-FREE DNA END CHARACTERISTICS
#28PLACENTAL PROTEIN BIOMARKERS FOR GESTATIONAL AGE ASSESSMENT AND RELATED METHODS
#29DETECTION OF MICROPARTICLE-ASSOCIATED PROTEINS ASSOCIATED WITH SPONTANEOUS PRETERM BIRTH
#30USE OF FIBRONECTIN IN PREDICTING PREECLAMPSIA
#31BIOMARKER PAIRS AND TRIPLETS FOR PREDICTING PRETERM BIRTH
#32METHOD OF PROGNOSING PREECLAMPSIA
#33METHOD FOR DETERMINING PERSONALIZED OMEGA-3 DOSE
#34METHOD AND KIT FOR PREDICTING PREECLAMPSIA
#35Kits and methods to distinguish false labor and true labor
#36METABOLIC PROFILE SCREENING FOR GESTATIONAL DIABETES
#37Blood Preparation and Profiling
#38METHODS AND MATERIALS FOR ASSESSING AND TREATING HYPERTENSIVE DISORDERS
#39APPARATUS AND METHOD FOR DETECTING MISFOLDED PROTEIN IN BIOLOGICAL SAMPLE
#40METHODS OF ASSESSING RISK OF AND TREATING PREECLAMPSIA AND SUBTYPES THEREOF
#41Pregnancy clock proteins for predicting due date and time to birth
#42COMBINATION OF BIOMARKERS OF PRETERM DELIVERY
#43Systems and methods to identify and treat subjects at risk for obstetrical complications
#44A Newborn Metabolic Vulnerability Model For Identifying Preterm Infants At Risk Of Adverse Outcomes, And Uses Thereof
#45CIRCULATING TROPHOBLASTS AS A NEW BIOMARKER FOR RISK ASSESSMENT OF MORBIDLY ADHERENT PLACENTATION
#46REAGENTS, METHODS AND KITS FOR IDENTIFYING PREGNANT HUMAN BEINGS AT RISK FOR PLACENTAL BED DISORDER(S)
#47Method of processing a biological sample
#48Method for Determining Risk of Pre-Term Birth
#49ANALYTIC METHOD AND KIT FOR DIAGNOSING RECURRENT MISCARRIAGE
#50DEVICES, ASSAYS AND METHODS OF TESTING PREECLAMPSIA
#51A METHOD OF DIAGNOSING AND/OR PROGNOSING PREECLAMPSIA
#52Biomarker for preeclampsia
#53ISOLATION OF FETAL CELLS USING FACS
#54Detection and Treatment of Pregnancy Complications Comprising Determining Sialyl Lewis Antigens and Administering hCG
#55PREECLAMPSIA BIOMARKERS AND USE THEREOF
#56ASSESSMENT OF PREECLAMPSIA USING ASSAYS FOR FREE AND DISSOCIATED PLACENTAL GROWTH FACTOR
#57BIOMARKER COMPOSITION FOR DIAGNOSING PRE-ECLAMPSIA AND USE THEREOF
#58PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#59BIOMARKERS
#60ANALYZING HORMONE PANELS FOR THE PREDICTION OF SPONTANEOUS PRETERM DELIVERY
#61PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#62METHODS FOR PREDICTING TIME-TO-DELIVERY IN PREGNANT WOMEN
#63Targeted apheresis to treat preeclampsia
#64METHODS FOR PREDICTING AND REDUCING THE RISK OF PRETERM BIRTH
#65BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#66Biomarker Pairs of Preterm Birth
#67TROPHOBLAST STEM CELL, METHODS OF PREPARATION AND USES THEREOF
#68DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME
#69Kits and methods to distinguish false labor and true labor
#70METHOD FOR DETECTING IMMINENT CHILDBIRTH
#71Methods and compositions for detecting misfolded proteins
#72COMPOSITIONS AND METHODS OF PROGNOSIS AND CLASSIFICATION FOR PREECLAMPSIA
#73Diagnostic assay and treatment for preeclampsia
#74Assessment of preeclampsia using assays for free and dissociated placental growth factor
#75PREECLAMPSIA DIAGNOSTIC DEVICES, SYSTEMS AND METHODS
#76Preeclampsia biomarkers and related systems and methods
#77ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA
#78USE OF CIRCULATING MICROPARTICLES TO STRATIFY RISK OF SPONTANEOUS PRETERM BIRTH
#79METHODS AND KITS FOR DETECTING MISFOLDED PROTEINS
#80Detection of microparticle-associated proteins associated with spontaneous preterm birth
#81Isolation of fetal cells using FACS
#82CIRCULATORY BIOMARKERS FOR PLACENTAL OR FETAL HEALTH
#83BIOMARKERS FOR PREDICTING PRETERM BIRTH DUE TO PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) VERSUS IDIOPATHIC SPONTANEOUS LABOR (PTL)
#84Assessment of preeclampsia using assays for free and dissociated placental growth factor
#85INFECTION-RELATED PRETERM BIRTH DIAGNOSTIC METHOD
#86BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#87CIRCULATING RNA SIGNATURES SPECIFIC TO PREECLAMPSIA
#88PREDICTION OF PREECLAMPSIA BASED ON IGFBP-7
#89SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS
#90BIOMARKERS AND USES THEREOF
#91Methods for identifying and monitoring pregnant women at risk of preeclampsia
#92Treatment of Placental Chronic Histiocytic Intervillositis Using an Inhibitor of Interleukin-1
#93Combinations of cell free nucleic acids
#94Superhydrophobic platform for sensing urine metabolites and toxins
#95Methods and compositions for treating pre-eclampsia
#96METHODS OF PREDICTING PRE TERM BIRTH FROM PREECLAMPSIA USING METABOLIC AND PROTEIN BIOMARKERS
#97Placental protein biomarkers for gestational age assessment and related methods
#98Ratios of sFlt-1 to P1GF or endoglin to P1GF as biomarkers for preeclampsia related adverse outcomes after birth
#99COMPOSITIONS AND METHODS FOR FETAL GROWTH
#100Biomarkers of Preterm Birth
#101IMMUNE AND GROWTH-RELATED BIOMARKERS ASSOCIATED WITH PRETERM BIRTH ACROSS SUBTYPES AND PREECLAMPSIA DURING MID-PREGNANCY, AND USES THEREOF
#102Noninvasive molecular controls
#103METHODS AND DEVICES FOR DETECTING BIOMARKERS ASSOCIATED WITH PREECLAMPSIA
#104Serum/plasma LncRNA marker composition associated with auxiliary diagnosis of intrahepatic cholestasis of pregnancy and application thereof
#105PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#106COMPOSITIONS COMPRISING LIGANDS TO RHOB PROTEIN AND THE USES THEREOF
#107CELL-FREE DNA END CHARACTERISTICS
#108Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#109DETECTION OF PREDICTORS OF PREECLAMPSIA
#110Methods for identification of pregnancy failure
#111Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#112Methods for measuring gene expression levels to identify viable oocytes
#113Diagnostic assay and treatment for preeclampsia
#114Method for determining the risk of preterm birth
#115NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY
#116A NEW BIOMARKER FOR PREECLAMPSIA
#117BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#118BIOMARKERS FOR PREDICTING PRETERM BIRTH IN A PREGNANT FEMALE EXPOSED TO PROGESTOGENS
#119Methods and compositions for detecting misfolded proteins
#120METHODS AND COMPOSITIONS FOR PROVIDING PREECLAMPSIA ASSESSMENT
#121COMPOSITIONS AND METHODS FOR PREDICTING RISK OF PRETERM BIRTH
#122In vitro method for identifying a pregnancy related disease
#123MARKERS AND THEIR RATIO TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA
#124BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#125Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
#126Systems and methods to identify and treat subjects at risk for obstetrical complications
#127Kisspeptin-54 detection by tandem mass spectrometry
#128Pregnancy clock proteins for predicting due date and time to birth
#129DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME
#130BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#131Assay Method For Determining The Risk Of Pre-Eclampsia
#132METHOD OF TREATMENT AND PROGNOSIS
#133Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models
#134BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#135Analysis of amino acids in body fluid by liquid chromotography-mass spectrometry
#136System and method for determining risk of diabetes based on biochemical marker analysis
#137Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#138METHODS AND COMPOSITIONS FOR PROGNOSING PRETERM BIRTH
#139METHOD OF ANALYSING A BLOOD SAMPLE OF A SUBJECT FOR THE PRESENCE OF A FOETAL DISEASE OR CONDITION MARKER
#140Method for producing animal model of preterm birth and animal model of preterm birth produced by the method
#141PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#142Tools for Predicting the Risk of Preterm Birth
#143METHOD FOR DETECTING IMMINENT CHILDBIRTH
#144Detection of risk of pre-eclampsia
#145Methods of predicting preeclampsia using biomarkers
#146Treatment of spontaneous preterm birth
#147Method for detecting chemical substances in samples of material that can be taken from a subject, in particular for detecting embryotoxic factors
#148IGFBP-7 as a marker of preeclampsia
#149Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#150Kits and methods to distinguish false labor and true labor
#151SERUM LIPID BIOMARKERS OF PREECLAMPSIA
#152Blood preparation and profiling
#153Systems and methods to predict risk for preterm labor and/or preterm birth
#154Methods for identification of pregnancy failure
#155Diagnosis and treatment of preeclampsia
#156Combinations of cell free nucleic acids
#157In vitro method for identifying a pregnancy related disease
#158Microparticle fractionation
#159HIGH-THROUGHPUT EARLY DETECTION AND POINT-OF-CARE EARLY DETECTION OF PREGNANT WOMEN SUSCEPTIBLE TO DEVELOPING PREECLAMPSIA
#160METHODS AND COMPOSITIONS FOR DIAGNOSIS OF ECTOPIC PREGNANCY
#161THERAPEUTIC STRATEGIES FOR THE TREATMENT OF PREECLAMPSIA
#162Determining candidate for induction of labor
#163Screening asymptomatic pregnant woman for preterm birth
#164BIOMARKERS FOR PREDICTING PRETERM BIRTH DUE TO PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) VERSUS IDIOPATHIC SPONTANEOUS LABOR (PTL)
#165BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#166SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS
#167Methods for predicting time-to-delivery in pregnant women
#168Kisspeptin-54 detection by tandem mass spectrometry
#169Antibody Therapy for Amyloid Beta Disease
#170BIOMARKERS FOR PREDICTING PRETERM BIRTH IN A PREGNANT FEMALE EXPOSED TO PROGESTOGENS
#171Biomarkers for assessment of preeclampsia
#172BIOMARKERS FOR PREECLAMPSIA
#173DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#174Diagnostic assay and treatment for preeclampsia
#175Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction
#176Non-invasive biomarker to identify subject at risk of preterm delivery
#177Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby
#178MEANS AND METHODS FOR NON-INVASIVE DIAGNOSIS OF CHROMOSOMAL ANEUPLOIDY
#179Methods and kits for detecting misfolded proteins
#180MARKERS OF PRETERM BIRTH
#181PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#182METHODS FOR DETECTING GESTATIONAL DIABETES MELLITUS
#183EARLY PREDICTION OF PREECLAMPSIA
#184CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT
#185Methods For Providing A Prognosis Of Pregnancy
#186Method for determining risk of pre-eclampsia
#187Method for determining the risk of preterm birth
#188Methods Of Detecting Ectopic Pregnancy
#189METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCY
#190Systems and methods to identify and treat subjects at risk for obstetrical complications
#191Diagnosis, and anti-mullerian hormone (AMH) administration for treatment, of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models
#192Methods and compositions for diagnosis of ectopic pregnancy
#193Maternal chelation for embryo, fetal and infant benefit
#194BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#195Synthetic antigen compositions for detecting anti-phosphatidylethanolamine antibodies
#196Markers for preeclampsia
#197Oxidized LDL as a biomarker for neurological complications of pregnancy
#198Prognostic assay for success of assisted reproductive technology
#199Methods and reagents for the assessment of gestational diabetes
#200EARLY DETECTION OF PREECLAMPSIA
#201Methods of diagnosing and treating complications of pregnancy
#202FERTILITY AND PREGNANCY MONITORING DEVICE AND METHOD
#203Using light to regulate uterine contractions
#204ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 Receptor
#205Modulation of inflammation using progesterone metabolites
#206Devices And Methods For Detecting Amniotic Fluid In Vaginal Secretions
#207Device for detecting misfolded proteins and methods of use thereof
#208Method diagnosis of a prenatal disorder by selective determination of placental growth factor 2
#209PREDICTION OF PREECLAMPSIA USING MICRORNA
#210Isoform specific soluble FMS-like tyrosine kinase (sFlt) binding agents and uses thereof
#211Microparticle fractionation
#212Devices and methods for detecting amniotic fluid in vaginal secretions
#213PREDICTION OF POSTPARTUM HELLP SYNDROME, POSTPARTUM ECLAMPSIA OR POSTPARTUM PREECLAMPSIA
#214System and Method for Determining Risk of Pre-Eclampsia Based on Biochemical Marker Analysis
#215Methods for Determining The Risk of Prenatal Complications
#216Telocinobufagin (TCINO) in the Diagnosis and Pathogenesis of Preeclampsia, Traumatic Brain Injury and Acute Respiratory Distress Syndrome
#217Methods for predicting time-to-delivery in pregnant women
#218DIAGNOSIS OF FOETAL DISTRESS
#219DETECTION OF RISK OF PRE-ECLAMPSIA
#220Antibody therapy for amyloid beta disease
#221Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome
#222Methods of treating pre-eclampsia or eclampsia
#223CONTROL OF UTERINE CONTRACTIONS
#224BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#225Methods of detecting prenatal or pregnancy-related diseases or conditions
#226Methods and kits for detecting misfolded proteins
#227Diagnostic biomarker to predict women at risk for preterm delivery
#228Detection of intraamniotic and/or infection
#229DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#230Biomarkers for hypertensive disorders of pregnancy
#231SERUM-BASED, DIAGNOSTIC, BIOLOGICAL ASSAY TO PREDICT PREGNANCY DISORDERS
#232Pre-eclampsia biomarkers
#233PROGNOSTIC MARKER TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA
#234BIOMARKERS FOR ASSESSMENT OF PREECLAMPSIA
#235Methods of Prognosing Preeclampsia
#236Application of N-terminomics to NETosis in inflammation
#237METHODS AND COMPOSITIONS FOR DIAGNOSING PREECLAMPSIA
#238BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#239DIAGNOSTIC TOOLS TO PREDICT ONSET OF PREECLAMPSIA
#240Therapeutic strategies for the treatment of preeclampsia
#241Treatment of spontaneous preterm birth
#242Means and methods applying sFlt-1/PlGF or endoglin/PlGF ratio to rule out onset of preeclampsia within a certain time period
#243METHOD AND SYSTEM FOR DIAGNOSING AND TREATING PREECLAMPSIA
#244DETECTION AND TREATMENT OF PREGNANCY COMPLICATIONS
#245Methods and compositions for detecting misfolded proteins
#246SNP FOR PREDICTING EFFECTIVENESS OF PRETERM BIRTH DIAGNOSTIC TEST
#247Non-invasive biomarker to identify subject at risk of preterm delivery
#248Markers for preeclampsia
#249Identification and analysis of fetal trophoblast cells in cervical mucus for prenatal diagnosis
#250MARKER FOR PRETERM LABOUR
#251PREDICTION OF A SMALL-FOR-GESTATIONAL AGE (SGA) INFANT
#252HIGH-THROUGHPUT EARLY DETECTION AND POINT-OF-CARE EARLY DETECTION OF PREGNANT WOMEN SUSCEPTIBLE TO DEVELOPING PREECLAMPSIA
#253Methods of predicting and decreasing the risk of pre-term birth
#254Early Predictive Markers of Pre-Eclampsia
#255Kisspeptin-54 detection by tandem mass spectrometry
#256Method for the Selection of Serum Biomarkers of Epigenetic Alterations, Particularly of Global Hypomethylation and Their Uses
#257Methods and Compositions for Providing a Preeclampsia Assessment
#258EARLY TRIMESTER SCREENING FOR EARLY- AND LATE-ONSET PREECLAMPSIA
#259Methods for detecting oncofetal fibronectin
#260Maternal biomarkers for gestational diabetes
#261Use of relaxin to treat placental syndromes
#262METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY HCG ASSAY
#263DIAGNOSTIC AND PROGNOSTIC USE OF PROMBP-COMPLEXES
#264Determination of sFlt-1:angiogenic factor complex
#265BIOMARKERS AND PARAMETERS FOR PREECLAMPSIA
#266GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
#267Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
#268Therapeutic agent for preterm delivery or abortion using plasminogen activator inhibitor-1
#269System and method for determining risk of diabetes based on biochemical marker analysis
#270Dynamic of sFlt-1 or endoglin/PLGF ratio as an indicator for imminent preeclampsia and/or HELLP syndrome
#271Methods of use for an immunoassay detecting fragment Ba
#272Methods for determining the risk of prenatal complications
#273Methods for treatment of autism
#274Using light to regulate uterine contractions
#275Oxidized LDL as a biomarker for neurological complications of pregnancy
#276Devices and methods for detecting amniotic fluid in vaginal secretions
#277Leukocyte activation and methods of use thereof
#278Antibodies against human HIF-1α
#279Methods for reducing the risk of spontaneous abortion in a human female comprising administering an effective amount of G-CSF
#280Methods for detecting oncofetal fibronectin
#281USE OF ANTI-PLAC1 PROTEIN ANTIBODIES AS BIOMARKERS OF INFERTILITY, DIAGNOSTIC KIT FOR THE DETECTION OF THE IMMUNE RESPONSE AGAINST PLAC1 AND USE OF PLAC1 PROTEIN IN THERAPEUTIC AND CONTRACEPTIVE FIELDS
#282BIOMARKER FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#283Detection of risk of pre-eclampsia
#284Devices and methods for detecting amniotic fluid in vaginal secretions
#285Methods and kits for detecting ITA in a biological sample
#286BIOMARKERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#287Means and methods for non-invasive diagnosis of chromosomal aneuploidy
#288Methods for predicting pregnancy outcome in a subject by hCG assay
#289Methods of use for an immunoassay detecting fragment Ba
#290Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation
#291METHOD OF PREDICTING RISK OF PRE-TERM BIRTH
#292Compositions and methods for reducing the risk of preterm labor
#293Methods and kits to detect and monitor ovarian cancer and preeclampsia
#294Compositions and methods for reducing the risk of preeclampsia
#295Monoclonal antibody against human HIG-1 polypeptide
#296DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#297Methods and compositions for diagnosis of ectopic pregnancy
#298Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
#299MARKER
#300Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications